A rare and alarming hantavirus outbreak aboard a cruise ship has led to multiple deaths and evacuations, raising concerns among health officials about the potential for further spread and the need for improved global preparedness.

As of May 6, 2026, at least seven cases of hantavirus infection have been confirmed on a cruise ship traveling from Argentina, including three deaths and one critically ill patient. The outbreak, primarily linked to the Andes strain of hantavirus, has prompted rapid response measures, including the evacuation of dozens of passengers and the deployment of private aircraft for medical transport.

The European Centre for Disease Prevention and Control (ECDC) reported that the cruise ship, initially docked off the coast of Cape Verde, had begun moving toward the Canary Islands after three passengers were evacuated for treatment. Health authorities have emphasized that no symptomatic passengers remain on board, but the situation remains under close monitoring.

Hantavirus, a family of viruses primarily spread through contact with rodent urine, droppings, or saliva, can cause severe respiratory illness and, in some cases, fatal hantavirus pulmonary syndrome. The Andes strain is particularly concerning due to its ability to spread from person to person, a rare but dangerous characteristic among hantaviruses.

Experts are weighing in on whether hantavirus could become the next global pandemic. While the current outbreak is isolated, its severity and the virus’s potential for human-to-human transmission have sparked discussions about the need for better surveillance and vaccine development. According to the ECDC, the risk to Europe remains low but is being assessed continuously.

The public health expert who led the White House’s response to the coronavirus pandemic under the Biden administration recently stated that, while the current hantavirus outbreak is serious, it is unlikely to become the next global pandemic. However, the situation underscores the importance of global health vigilance and preparedness.

In response to the outbreak, four hantavirus vaccines are currently undergoing clinical trials. These vaccines target different strains of the virus, including Hantaan and Puumala, which are prevalent in Asia and Europe, respectively. Researchers are optimistic that these trials could pave the way for effective prevention strategies, though no FDA-approved vaccine for hantavirus is currently available.

For travelers and the public, health officials recommend taking precautions to avoid rodent exposure, such as sealing entry points to homes and avoiding contact with wild rodents. Symptoms of hantavirus infection, including fever, muscle aches, and difficulty breathing, should prompt immediate medical attention.

As the cruise ship continues its journey and health authorities work to contain the outbreak, the global health community remains on high alert. The situation serves as a reminder of the ongoing need for robust infectious disease surveillance and rapid response capabilities in an increasingly interconnected world.